Similar articles

• Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.

  El-Bialy G, Kassab A, Armstrong M. El-Bialy G, et al. Arch Gynecol Obstet. 2007 Oct;276(4):371-3. doi: 10.1007/s00404-007-0351-3. Epub 2007 Mar 14. Arch Gynecol Obstet. 2007. PMID: 17356825
• Placenta increta: evaluation of radiological investigations and therapeutic options of conservative management.

  Panoskaltsis TA, Ascarelli A, de Souza N, Sims CD, Edmonds KD. Panoskaltsis TA, et al. BJOG. 2000 Jun;107(6):802-6. doi: 10.1111/j.1471-0528.2000.tb13345.x. BJOG. 2000. PMID: 10847240 No abstract available.
• Placenta percreta: methotrexate treatment and MRI findings.

  Heiskanen N, Kröger J, Kainulainen S, Heinonen S. Heiskanen N, et al. Am J Perinatol. 2008 Feb;25(2):91-2. doi: 10.1055/s-2007-1004831. Epub 2008 Jan 4. Am J Perinatol. 2008. PMID: 18176907
• Conservative management of placenta increta: case report and literature review.

  Yarandi F, Eftekhar Z, Shojaei H, Rahimi-Sharbaf F, Baradaran F. Yarandi F, et al. Acta Med Iran. 2011;49(6):396-8. Acta Med Iran. 2011. PMID: 21874645 Review.
• Using methotrexate to treat placenta accreta.

  Cole MD. Cole MD. AWHONN Lifelines. 2002 Dec;6(6):486-7. doi: 10.1177/1091592302239619. AWHONN Lifelines. 2002. PMID: 12593248 Review. No abstract available.